Investment Analysts’ Price Target Changes for November 11th (AHR, AMBQ, ANF, ARMK, AZTA, BRX, CF, COLD, CTRE, DOC)

Investment Analysts’ price target changes for Wednesday, November 11th:

American Healthcare REIT (NYSE:AHR) had its target price increased by UBS Group from $62.00 to $71.00. The firm currently has a buy rating on the stock.

Ambiq Micro (NYSE:AMBQ) had its target price boosted by UBS Group from $50.00 to $52.00. The firm currently has a neutral rating on the stock.

Ambiq Micro (NYSE:AMBQ) had its price target cut by Jefferies Financial Group from $90.00 to $70.00. They currently have a buy rating on the stock.

Abercrombie & Fitch (NYSE:ANF) had its target price increased by UBS Group from $185.00 to $200.00. UBS Group currently has a buy rating on the stock.

Aramark (NYSE:ARMK) had its price target reduced by UBS Group from $71.00 to $65.00. The firm currently has a buy rating on the stock.

Azenta (NASDAQ:AZTA) had its target price boosted by Jefferies Financial Group from $44.00 to $52.00. Jefferies Financial Group currently has a buy rating on the stock.

Brixmor Property Group (NYSE:BRX) had its target price boosted by UBS Group from $33.00 to $35.00. UBS Group currently has a buy rating on the stock.

CF Industries (NYSE:CF) had its price target raised by Freedom Broker from $129.00 to $133.00. They currently have a hold rating on the stock.

CF Industries (NYSE:CF) had its target price trimmed by UBS Group from $134.00 to $133.00. The firm currently has a neutral rating on the stock.

Americold Realty Trust (NYSE:COLD) had its price target increased by UBS Group from $14.00 to $16.00. They currently have a neutral rating on the stock.

CareTrust REIT (NYSE:CTRE) had its target price raised by UBS Group from $44.00 to $46.00. The firm currently has a buy rating on the stock.

Healthpeak Properties (NYSE:DOC) had its target price raised by UBS Group from $20.00 to $22.00. UBS Group currently has a neutral rating on the stock.

Diamondback Energy (NASDAQ:FANG) had its target price increased by UBS Group from $260.00 to $263.00. They currently have a buy rating on the stock.

FactSet Research Systems (NYSE:FDS) had its price target boosted by UBS Group from $340.00 to $375.00. UBS Group currently has a buy rating on the stock.

Federal Realty Investment Trust (NYSE:FRT) had its target price raised by UBS Group from $115.00 to $121.00. UBS Group currently has a neutral rating on the stock.

Healthcare Realty Trust (NYSE:HR) had its target price increased by UBS Group from $18.00 to $20.00. UBS Group currently has a neutral rating on the stock.

Janus International Group (NYSE:JBI) had its target price trimmed by UBS Group from $5.60 to $4.80. The firm currently has a neutral rating on the stock.

Kimco Realty (NYSE:KIM) had its price target boosted by UBS Group from $25.00 to $29.00. The firm currently has a buy rating on the stock.

Kite Realty Group Trust (NYSE:KRG) had its target price raised by UBS Group from $26.00 to $27.00. UBS Group currently has a neutral rating on the stock.

MercadoLibre (NASDAQ:MELI) had its price target trimmed by UBS Group from $1,750.00 to $1,600.00. They currently have a neutral rating on the stock.

Nutrien (NYSE:NTR) had its target price reduced by Freedom Broker from $78.00 to $76.00. The firm currently has a hold rating on the stock.

Orion (NYSE:OEC) had its price target cut by UBS Group from $6.50 to $5.00. UBS Group currently has a neutral rating on the stock.

Omega Healthcare Investors (NYSE:OHI) had its target price boosted by UBS Group from $52.00 to $56.00. UBS Group currently has a buy rating on the stock.

ON (NYSE:ONON) had its target price cut by UBS Group from $73.00 to $65.00. They currently have a buy rating on the stock.

Onto Innovation (NYSE:ONTO) had its target price cut by Freedom Broker from $410.00 to $325.00. The firm currently has a buy rating on the stock.

Paysign (NASDAQ:PAYS) had its target price boosted by Ladenburg Thalmann & Co. Inc. from $14.00 to $15.25. They currently have a buy rating on the stock.

Phillips Edison & Company, Inc. (NASDAQ:PECO) had its target price boosted by UBS Group from $42.00 to $45.00. They currently have a neutral rating on the stock.

Prudential Financial (NYSE:PRU) had its target price boosted by UBS Group from $92.00 to $125.00. They currently have a neutral rating on the stock.

QT Imaging (NASDAQ:QTI) had its price target lowered by Ladenburg Thalmann & Co. Inc. to $12.00. They currently have a buy rating on the stock.

Regency Centers (NASDAQ:REG) had its price target raised by UBS Group from $77.00 to $82.00. The firm currently has a neutral rating on the stock.

Sabra Healthcare REIT (NASDAQ:SBRA) had its target price boosted by UBS Group from $20.00 to $22.00. The firm currently has a neutral rating on the stock.

Simon Property Group (NYSE:SPG) had its target price increased by UBS Group from $205.00 to $235.00. The firm currently has a neutral rating on the stock.

Transdigm Group (NYSE:TDG) had its price target reduced by UBS Group from $1,509.00 to $1,481.00. The firm currently has a buy rating on the stock.

Tronox (NYSE:TROX) had its price target trimmed by UBS Group from $4.50 to $2.75. UBS Group currently has a neutral rating on the stock.

Urban Edge Properties (NYSE:UE) had its target price raised by UBS Group from $21.00 to $22.00. UBS Group currently has a neutral rating on the stock.

Ventas (NYSE:VTR) had its price target boosted by UBS Group from $90.00 to $99.00. The firm currently has a neutral rating on the stock.

Welltower (NYSE:WELL) had its price target increased by UBS Group from $269.00 to $289.00. They currently have a buy rating on the stock.